Scientific article
OA Policy
English

Tyrosine kinase drug discovery: what can be learned from solved crystal structures?

Published in

ARKIVOC, no. 8, p. 38-49

Publication date

2006

Abstract

Understanding molecular recognition during ligand binding is crucial for rational drug design. Protein kinases are a well known pharmacological target, especially in the therapeutic area of cancer. Solved crystal structures of tyrosine kinase domains in complex with ligands deliver insight into the binding event. These experimental data were collected and analysed by means of molecular modelling techniques. Common molecular recognition patterns were depicted and studied among this class of proteins. The results of this analysis and the consequences for rational design of inhibitors are presented.

Keywords

  • Tyrosine kinase ligands
  • Molecular modelling
  • Ligand core
  • Inhibitor minimal requirements and conserved ligand-kinase interactions

Citation (ISO format)

MORETTI, Loris, TCHERNIN, Laura, SCAPOZZA, Leonardo. Tyrosine kinase drug discovery: what can be learned from solved crystal structures? In: ARKIVOC, 2006, n° 8, p. 38–49. doi: 10.3998/ark.5550190.0007.805

Main files (1)

Article (Published version)

Identifiers

Additional URL for this publication

http://hdl.handle.net/2027/spo.5550190.0007.805

Journal ISSN

1551-7004
574views
503downloads

Technical informations

Creation

27/01/2016 11:58:00

First validation

27/01/2016 11:58:00

Update

15/03/2023 00:07:24

Status update

15/03/2023 00:07:24

Last indexation

31/10/2024 02:41:39
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated